Commentary

Patients with agoraphobia are showing strength, resilience during the pandemic


 

The COVID-19 pandemic has exposed a wave of general and mental health-related problems, such as stress, addiction, weight gain, depression, and social isolation. Those problems have been exacerbated in patients with mental illness who are already struggling to cope with personal problems.

Dr. Richard Cohen, a psychiatrist who practices in Philadelphia, and Ms. Nancy Cohen, who holds an MBA from Temple University in Philadelphia with a focus on health care administration.

Dr. Richard Cohen and Ms. Nancy Cohen

One might expect those with agoraphobia to be adversely affected by the pandemic and experience increased feelings of anxiety. It appears that people with agoraphobia might especially feel uncertain of other people’s actions during this time. Some might perceive being alone and cut off from help, and those feelings might make them more susceptible to panic attacks.

In my (R.W.C.) clinical experience, however, my patients with agoraphobia are actually functioning better than usual throughout this challenging course.


Personalizing treatment

Agoraphobia is a type of anxiety disorder that often develops after a panic attack and involves an intense fear of a place or situation. In my 40 years of clinical experience, I have treated about 300 patients with agoraphobia, and all of them exhibit the following three symptoms: depression (from losses in life), dependency (dependent on other people to help with activities of daily living), and panic attacks (an abrupt surge of intense fear or intense discomfort that may cause a person to avoid crowded areas or other public spaces outside of the home).

To manage these clients, I individualize treatment and use different strategies for different patients to help them cope with their agoraphobia. I normally treat my agoraphobic patients with a combination of medication and therapy. I most often use a selective serotonin reuptake inhibitor (SSRI), and my SSRI drug of choice is usually paroxetine (Paxil). Or, instead of an SSRI, I sometimes prescribe a tricyclic antidepressant, often Tofranil (imipramine). As an adjunct, I might prescribe a benzodiazepine, Xanax (alprazolam), p.r.n. My prescription decision is based on a patient’s side effect profile, medical history, and close blood relatives’ responses to those medications.

The therapy I use is behavior modification with systematic desensitization and flooding. Desensitization is a coping technique that helps the patient overcome triggers associated with the panic attacks and anxiety. In normal times, I use both in vitro (imaginary) and in vivo (real situation) desensitization. However, during the pandemic, I can use only in vitro desensitization, since I am treating patients through phone calls and telemedicine rather than in-person visits.

I also teach my patients with agoraphobia relaxation techniques to work through their fears and anxieties, and thus to reduce feelings of stress and anxiety. The patients can practice these learned techniques on their own in an effort to reduce panic and avoidance behaviors, and create a relaxation response.

Treating the key symptoms

As stated earlier, all of my agoraphobic patients exhibit the following three symptoms: depression, dependency, and panic attacks.

  • Depression – My agoraphobia patients are less depressed during the pandemic and are not feeling intense losses as they did prepandemic.
  • Dependency – During the pandemic, everyone has been interdependent upon other people in their households. Therefore, the patients’ support systems are more readily available, and the patients can help others as much as others help them in their own households or “havens of safety.”
  • Panic attacks – As depression has declined, panic attacks have also declined, since they are interrelated.

Pages

Recommended Reading

Borderline personality disorder diagnosis: To tell or not to tell patients?
MDedge Psychiatry
Adult separation anxiety raises suicidality risk
MDedge Psychiatry
Shedding the super doctor myth
MDedge Psychiatry
Chauvin guilty verdict: Now it’s time to get to work
MDedge Psychiatry
What I want people to know about the Chauvin verdict
MDedge Psychiatry
Assessing perinatal anxiety: What to ask
MDedge Psychiatry
COVID lockdowns linked to PTSD in patients with eating disorders
MDedge Psychiatry
The cloudy role of cannabis as a neuropsychiatric treatment
MDedge Psychiatry
Police contact tied to elevated anxiety in young Black adults
MDedge Psychiatry
National poll shows ‘concerning’ impact of COVID on Americans’ mental health
MDedge Psychiatry